Hepatitis is a disease of the liver characterized by inflammation that impairs its ability to filter toxins, produce proteins, and metabolize nutrients. It results from viral infection, alcohol abuse, drug toxicity, or autoimmune conditions.
The liver is a important organ responsible for detoxifying blood, synthesizing proteins, and regulating metabolism. When infected or damaged, it loses function. Hepatitis disrupts these processes, leading to jaundice, fatigue, and long-term complications like cirrhosis or liver cancer.
According to the World Health Organization (WHO), hepatitis B and C are the most common viral causes, accounting for over 90% of chronic cases worldwide. The Centers for Disease Control and Prevention (CDC) reports that approximately 3.5 million people in the U.S. have chronic hepatitis B or C.
Hepatitis begins when the liver's immune system detects foreign agents-most often viruses. Immune cells flood the liver tissue to attack the invader, releasing inflammatory chemicals. This response damages healthy liver cells, causing swelling and scarring.
Acute hepatitis lasts less than six months. Chronic hepatitis persists beyond that period and increases the risk of permanent damage. For example, hepatitis B can remain dormant for years before triggering symptoms. In 15% of adults infected with hepatitis B, the virus becomes chronic.
Alcohol-related hepatitis occurs when excessive drinking overwhelms the liver's ability to process ethanol. Over time, fat accumulates in liver cells, leading to steatosis. Continued abuse leads to fibrosis and eventually cirrhosis-a condition where scar tissue replaces functional tissue.
There are five main types of hepatitis, each with distinct origins:
| Type | Cause | Transmission | Chronic Risk |
|---|---|---|---|
| A | Hepatitis A virus (HAV) | Fecal-oral route | None - resolves within weeks |
| B | Hepatitis B virus (HBV) | Blood, sexual contact, mother-to-child | 10% of adults develop chronic infection |
| C | Hepatitis C virus (HCV) | Blood exposure (e.g., IV drug use) | 75-85% progress to chronic form |
| D | Hepatitis D virus (HDV) | Requires HBV co-infection | Higher risk of severe liver disease |
| E | Hepatitis E virus (HEV) | Contaminated water (endemic in parts of Asia) | Rarely chronic; dangerous in pregnancy |
Autoimmune hepatitis is not infectious. It occurs when the body's immune system attacks liver cells. It affects women more than men, with a peak incidence between ages 15 and 40. Diagnosis requires ruling out viral causes through blood tests and liver biopsy.
Non-alcoholic fatty liver disease (NAFLD) is sometimes grouped under hepatitis due to similar inflammation patterns. It develops in people with obesity or insulin resistance. Up to 25% of adults in the U.S. have NAFLD, though only 5-10% progress to non-alcoholic steatohepatitis (NASH), which mimics viral hepatitis.
Many assume all hepatitis is contagious. That's false. Only viral forms (A, B, C, D, E) spread between people. Autoimmune and toxic hepatitis do not transmit via contact.
Another error is equating hepatitis with cirrhosis. While chronic hepatitis increases cirrhosis risk, they are not the same. Cirrhosis is a late-stage condition marked by irreversible scarring. Not everyone with hepatitis develops it.
For example, a person with mild hepatitis B may show normal liver enzymes and no symptoms. They can live decades without treatment. But if untreated, the virus can silently damage the liver over time. WHO estimates that 1 in 3 people with chronic hepatitis B will die prematurely from liver failure or cancer.
In 2018, a 42-year-old man in rural Ohio presented with yellowing skin and dark urine. Blood tests revealed elevated bilirubin and ALT levels. He had no history of alcohol use or IV drug use. Testing confirmed hepatitis C with genotype 1b.
He was unaware he'd been exposed during a dental procedure in 2005, when sterilization protocols were inconsistent. His infection had remained asymptomatic for 13 years. After starting direct-acting antiviral therapy (DAAs), his viral load dropped to undetectable levels within 12 weeks. Full recovery occurred in six months.
This case illustrates how hepatitis can remain hidden for years. Early detection prevents progression to advanced liver disease. Routine screening is recommended for anyone born between 1945 and 1965, as this cohort has a higher prevalence of undiagnosed hepatitis C.
Early symptoms include fatigue, nausea, and abdominal discomfort. These are non-specific and easily dismissed. More definitive signs include jaundice (yellow eyes or skin), pale stools, and dark urine.
If you've had unprotected sex, shared needles, or received a blood transfusion before 1992, testing is essential. The CDC recommends one-time screening for all adults aged 18 and older, regardless of risk factors.
For those with known exposure, follow-up care includes monitoring liver enzymes and imaging. Ultrasound can detect early signs of fibrosis. A FibroScan measures liver stiffness-values above 7.1 kPa indicate significant fibrosis.
Living with hepatitis doesn't mean living in fear. Effective treatments exist for viral forms. Antivirals can cure hepatitis C in over 95% of cases. Hepatitis B is managed with daily medication to suppress viral replication.
Hepatitis is a disease of the liver. Its impact depends on cause, duration, and timely intervention. Early diagnosis and treatment prevent irreversible damage and improve long-term outcomes.